Trade

Dr Agarwal's Eye Hospital share price

  • 36%Low risk
  • 36%Moderate risk
  • 36%Balanced risk
  • 36%High risk
  • 36%Extreme risk
  • 5,000.00(-0.28%)
    January 13, 2026 15:28:19 PM IST
    • NSE
    • BSE
  • Vol : 1.74 K (NSE + BSE)
    Last 20 day avg : 0.98 K

Dr Agarwal's Eye Hospital is trading -0.28% lower at Rs 5,000.00 as compared to its last closing price. Dr Agarwal's Eye Hospital has been trading in the price range of 5,118.95 & 4,952.00. Dr Agarwal's Eye Hospital has given -6.00% in this year & -4.57% in the last 5 days. Dr Agarwal's Eye Hospital has TTM P/E ratio 36.29 as compared to the sector P/E of 26.50.There are 3 analysts who have initiated coverage on Dr Agarwal's Eye Hospital. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 19.32 Crores in its last quarter.Listed peers of Dr Agarwal's Eye Hospital include Global Health (-2.17%), Max Healthcare Institute (1.45%), Fortis Healthcare (1.68%).The Mutual Fund holding in Dr Agarwal's Eye Hospital was at 0.18% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Dr Agarwal's Eye Hospital was at 1.74% in 30 Sep 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 13, 2026, 06:03 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.31
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.59
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.13
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    11.24
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    37.45
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.19
    Indicates Fair Valuation
Price range
Day Range
Lowest
4,952.00
Highest
5,118.95
52 week range
Lowest
3,500.00
Highest
7,010.00
Dr Agarwal's Eye Hospital Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Global Health
Bearish
1,167.85-2.1731,302.8461.739.450.0418.41
Max Healthcare Institute
Bearish
1,028.601.451,00,068.1293.4311.210.1429.50
Fortis Healthcare
Neutral
909.001.6868,625.7080.047.640.1125.92
Apollo Hospitals Enterprise
Bullish
7,308.200.581,04,887.2771.0912.560.2683.18
Narayana Hrudayalaya
Bullish
1,900.001.4338,852.4147.6610.510.2459.03
Mutual Fund Ownership
View all
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.99
  • % of AUM 0.60
PGIM India Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.26
  • % of AUM 0.23
PGIM India Retirement Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.19
  • % of AUM 0.22
Dr Agarwal's Eye Hospital Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-10-30Quarterly Results & Interim Dividend
2025-08-27Preferential Issue of shares
2025-08-12Quarterly Results
2025-05-28Audited Results & Final Dividend
2025-02-14Quarterly Results
About the company Dr Agarwal's Eye Hospital
  • IndustryHealthcare Facilities
  • ISININE934C01018
  • BSE Code526783
  • NSE Code
Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
  • Management Info
  • Amar AgarwalExecutive and Non-Independent Chairman of the Board, Managing Director
  • Yashwanth VenkatInterim Chief Financial Officer
  • Meenakshi JayaramanCompliance Officer, Company Secretary
  • Saradha GovindarajanCompliance Officer
  • Athiya AgarwalNon-Independent Whole Time Director
  • S. Lakshmi NarasimhanCompany Secretary
Dr Agarwal's Eye Hospital Share Price FAQs

Dr Agarwal's Eye Hospital is trading at 5000.00 as on Tue Jan 13 2026 09:58:19. This is -0.28% lower as compared to its previous closing price of 5014.10.

The market capitalization of Dr Agarwal's Eye Hospital is 2415.48 Cr as on Tue Jan 13 2026 09:58:19.

The average broker rating on Dr Agarwal's Eye Hospital is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Dr Agarwal's Eye Hospital is 7010.00 whereas the 52 wk low is 3500.00

Dr Agarwal's Eye Hospital can be analyzed on the following key metrics -

  • TTM P/E: 36.29
  • Sector P/E: 26.50
  • Dividend Yield: 0.13%
  • D/E ratio: 1.06

Dr Agarwal's Eye Hospital reported a net profit of 54.65 Cr in 2025.

The Mutual Fund Shareholding was 0.18% at the end of 30 Sep 2025.